SunWay Biotech Co., LTD. (TPEX: 1271)

SunWay Biotech Co., LTD. Revenue

SunWay Biotech Co., LTD. had revenue of 483.06M TWD in the half year ending June 30, 2024, with 174.29% growth. This brings the company's revenue in the last twelve months to 810.99M, up 64.69% year-over-year. In the year 2023, SunWay Biotech Co., LTD. had annual revenue of 571.11M with 34.27% growth.

• Revenue (ttm): 810.99M
• Revenue Growth: +64.69%
• P/S Ratio: 5.24
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	571.11M	145.76M	34.27%
Dec 31, 2022	425.35M	44.92M	11.81%
Dec 31, 2021	380.43M	65.96M	20.97%
Dec 31, 2020	314.48M	142.29M	82.64%
Dec 31, 2019	172.19M	63.54M	58.48%